WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX) and Applied BioCode (6598:Taipei) today announced that they have entered into an exclusive global agreement to bring Applied ...
WESTBROOK, Maine, Aug. 15, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that its U.S. reference laboratory ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 fourth quarter and full year financial results for Monday, February 2, 2026 ...
WESTBROOK, Maine, Jan. 19, 2015 /PRNewswire/ -- IDEXX Laboratories, Inc. announced today an upcoming kidney test, called SDMA, promising to transform the way veterinarians diagnose and treat kidney ...
IDEXX Laboratories IDXX has shown remarkable momentum, rallying 64.7% in the last 12 months. The stock has comfortably surpassed the industry’s 2.8% growth and the S&P 500 Composite’s 17.7% gain.
Good morning, and welcome to the IDEXX Laboratories Third Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded. Participating in the call this morning are Jay ...
Instrument placements gave birth to sales of high-margin consumables. The hurricanes hurt sales a little. And less testing of cattle is hurting the company's farm-animal testing business, although ...
IDEXX Laboratories, Inc. IDXX is slated to report first-quarter 2020 results on Apr 30, before market open. In the last reported quarter, the company delivered a positive earnings surprise of 14.29%.